Bfsg LLC increased its stake in Amrize Ltd (NYSE:AMRZ – Free Report) by 103.9% in the 3rd quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 133,924 shares of the company’s stock after purchasing an additional 68,247 shares during the period. Bfsg LLC’s holdings in Amrize were worth $6,499,000 as of its most recent SEC filing.
A number of other hedge funds have also recently bought and sold shares of the company. Vanguard Group Inc. bought a new stake in shares of Amrize during the second quarter worth $1,065,029,000. Norges Bank acquired a new stake in Amrize in the second quarter worth about $670,915,000. Dodge & Cox bought a new stake in Amrize during the 2nd quarter worth about $622,085,000. JPMorgan Chase & Co. acquired a new position in Amrize during the 2nd quarter valued at about $220,404,000. Finally, Allspring Global Investments Holdings LLC boosted its stake in shares of Amrize by 247.0% in the 3rd quarter. Allspring Global Investments Holdings LLC now owns 4,386,926 shares of the company’s stock valued at $212,449,000 after purchasing an additional 3,122,716 shares during the last quarter.
Wall Street Analysts Forecast Growth
A number of equities research analysts recently weighed in on AMRZ shares. Oppenheimer boosted their price target on shares of Amrize from $62.00 to $64.00 and gave the stock an “outperform” rating in a research note on Thursday. Stephens initiated coverage on Amrize in a report on Friday, November 14th. They set an “overweight” rating and a $60.00 price objective on the stock. Vertical Research initiated coverage on shares of Amrize in a report on Tuesday, November 25th. They set a “hold” rating and a $54.00 price objective on the stock. Kepler Capital Markets upgraded Amrize to a “strong-buy” rating in a report on Tuesday, October 21st. Finally, Wall Street Zen upgraded Amrize to a “hold” rating in a report on Saturday, October 25th. One equities research analyst has rated the stock with a Strong Buy rating, eight have assigned a Buy rating and six have given a Hold rating to the stock. Based on data from MarketBeat, the company has an average rating of “Moderate Buy” and an average price target of $60.67.
Insiders Place Their Bets
In other Amrize news, CTO Roald Brouwer acquired 4,000 shares of the company’s stock in a transaction on Friday, October 31st. The shares were purchased at an average price of $51.77 per share, for a total transaction of $207,080.00. Following the completion of the purchase, the chief technology officer directly owned 9,000 shares of the company’s stock, valued at approximately $465,930. This represents a 80.00% increase in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through the SEC website. Also, Director Nicholas C. Gangestad acquired 2,000 shares of the business’s stock in a transaction dated Wednesday, November 19th. The stock was acquired at an average cost of $47.34 per share, with a total value of $94,680.00. Following the completion of the transaction, the director owned 4,958 shares of the company’s stock, valued at approximately $234,711.72. The trade was a 67.61% increase in their ownership of the stock. The SEC filing for this purchase provides additional information. Insiders bought 65,000 shares of company stock worth $3,399,720 in the last three months.
Amrize Stock Performance
NYSE:AMRZ opened at $54.52 on Friday. The company has a market capitalization of $30.15 billion and a PE ratio of 29.63. Amrize Ltd has a 1-year low of $44.12 and a 1-year high of $58.11. The firm has a fifty day moving average price of $53.17. The company has a quick ratio of 0.97, a current ratio of 1.45 and a debt-to-equity ratio of 0.38.
Amrize (NYSE:AMRZ – Get Free Report) last posted its quarterly earnings results on Wednesday, October 29th. The company reported $0.98 earnings per share (EPS) for the quarter, missing the consensus estimate of $1.01 by ($0.03). The business had revenue of $3.68 billion for the quarter, compared to analysts’ expectations of $3.49 billion. The business’s revenue for the quarter was up 6.6% compared to the same quarter last year.
Amrize Company Profile
Amrize AG focuses on building materials business in North America. The company was incorporated in 2023 and is based in Zug, Switzerland. Amrize AG operates independently of Holcim AG as of June 23, 2025.
Featured Articles
- Five stocks we like better than Amrize
- Elon Taking SpaceX Public! $100 Pre-IPO Opportunity!
- Do not delete, read immediately
- How a Family Trust May Be Able To Help Preserve Your Wealth
- URGENT: Trump Just Triggered AI’s Biggest Disruption Yet
- Wall Street Alert: Buy AES
Want to see what other hedge funds are holding AMRZ? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Amrize Ltd (NYSE:AMRZ – Free Report).
Receive News & Ratings for Amrize Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Amrize and related companies with MarketBeat.com's FREE daily email newsletter.
